CompanyPrivateSan Diego, CA

Avidity Biosciences, Inc

SEC EDGAR ClinicalTrials.gov

424B5Nov 10Latest SEC filing

Form DMar 19$400M sold

October 2026

Atrium Therapeutics amends 8-K to fix share count after PIPE offering

Oct 9FinancingAtrium Therapeutics